GAMMA Investing LLC Makes New $27,000 Investment in Bath & Body Works, Inc. (NYSE:BBWI)

GAMMA Investing LLC purchased a new position in shares of Bath & Body Works, Inc. (NYSE:BBWI) during the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm purchased 635 shares of the company’s stock, valued at approximately $27,000.

A number of other hedge funds and other institutional investors also recently made changes to their positions in BBWI. Darsana Capital Partners LP bought a new position in shares of Bath & Body Works during the third quarter worth $76,050,000. Earnest Partners LLC boosted its position in shares of Bath & Body Works by 1,055,015.7% during the third quarter. Earnest Partners LLC now owns 1,276,690 shares of the company’s stock worth $43,152,000 after purchasing an additional 1,276,569 shares in the last quarter. Newport Trust Company LLC bought a new position in shares of Bath & Body Works during the third quarter worth $24,721,000. Victory Capital Management Inc. boosted its position in shares of Bath & Body Works by 339.0% during the third quarter. Victory Capital Management Inc. now owns 638,806 shares of the company’s stock worth $21,592,000 after purchasing an additional 493,297 shares in the last quarter. Finally, Sound Shore Management Inc CT bought a new position in shares of Bath & Body Works during the third quarter worth $13,424,000. 95.14% of the stock is owned by institutional investors.

Insider Transactions at Bath & Body Works

In other news, insider Thomas E. Mazurek sold 4,285 shares of the business’s stock in a transaction dated Wednesday, March 27th. The shares were sold at an average price of $48.89, for a total transaction of $209,493.65. Following the transaction, the insider now directly owns 45,992 shares in the company, valued at approximately $2,248,548.88. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. 0.19% of the stock is owned by company insiders.

Analyst Ratings Changes

A number of equities analysts have recently weighed in on BBWI shares. Robert W. Baird lifted their price target on shares of Bath & Body Works from $50.00 to $54.00 and gave the stock an “outperform” rating in a research report on Friday, March 1st. Telsey Advisory Group reaffirmed an “outperform” rating and issued a $53.00 price objective on shares of Bath & Body Works in a research report on Friday, April 5th. BMO Capital Markets boosted their price objective on shares of Bath & Body Works from $48.00 to $50.00 and gave the company an “outperform” rating in a research report on Friday, March 1st. UBS Group boosted their price objective on shares of Bath & Body Works from $46.00 to $52.00 and gave the company a “neutral” rating in a research report on Monday, March 4th. Finally, The Goldman Sachs Group boosted their price objective on shares of Bath & Body Works from $49.00 to $56.00 and gave the company a “buy” rating in a research report on Monday, March 4th. One investment analyst has rated the stock with a sell rating, seven have assigned a hold rating and six have issued a buy rating to the company’s stock. Based on data from MarketBeat, the company currently has an average rating of “Hold” and an average price target of $46.73.

Bath & Body Works Price Performance

Shares of NYSE:BBWI opened at $47.38 on Tuesday. The company’s 50-day moving average price is $46.07 and its two-hundred day moving average price is $41.15. Bath & Body Works, Inc. has a one year low of $27.30 and a one year high of $50.34. The stock has a market capitalization of $10.66 billion, a PE ratio of 12.31, a price-to-earnings-growth ratio of 1.49 and a beta of 1.89.

Bath & Body Works (NYSE:BBWI) last issued its quarterly earnings results on Thursday, February 29th. The company reported $2.06 EPS for the quarter, topping the consensus estimate of $1.85 by $0.21. The firm had revenue of $2.91 billion for the quarter, compared to analysts’ expectations of $2.84 billion. Bath & Body Works had a net margin of 11.82% and a negative return on equity of 37.01%. The company’s revenue for the quarter was up .8% on a year-over-year basis. During the same period in the previous year, the firm posted $1.86 EPS. On average, analysts anticipate that Bath & Body Works, Inc. will post 3.3 earnings per share for the current fiscal year.

Bath & Body Works Announces Dividend

The company also recently disclosed a quarterly dividend, which was paid on Friday, March 8th. Stockholders of record on Friday, February 23rd were paid a dividend of $0.20 per share. The ex-dividend date of this dividend was Thursday, February 22nd. This represents a $0.80 annualized dividend and a dividend yield of 1.69%. Bath & Body Works’s dividend payout ratio is presently 20.78%.

About Bath & Body Works

Bath & Body Works, Inc operates a specialty retailer of home fragrance, body care, and soaps and sanitizer products. It sells its products under the Bath & Body Works, White Barn, and other brand names through retail stores and e-commerce sites located in the United States and Canada, as well as through international stores operated by partners under franchise, license, and wholesale arrangements.